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ABSTRACT 
 
Numerous studies have described that bacteria display higher resistance to 
antimicrobials when growing in biofilm mode of growth, however the phenotypic and 
virulence factors changes associated with this increased resistance are still poorly 
understood. 
The goal of this study was to enlarge the knowledge about the augmented biofilm-
related resistance of Pseudomonas aeruginosa characterizing phenotypically P. 
aeruginosa biofilms formed by different strains in order to find whether these bacterial 
biofilms display a common profile. This bacterium is a common opportunistic pathogen 
that is often related with persistent infections that cause high rates of patient morbidity 
and mortality due to its intrinsic resistance to several antimicrobials and great adaptive 
resistance to environmental stimuli. 
The experimental analysis consisted of a phenotypical examination comprising biofilm 
formation ability, susceptibility to antibiotics (ciprofloxacin and colistin), expression of 
several virulence factors (motility, toxin production, and slime production), and 
phenotypic switching. To best replicate real-world circumstances this work comprised 
the study of several P. aeruginosa strains: four reference strains (PAO1, ATCC 10145, 
CECT 111, and PA14) and three clinical isolates (PAI1, PAI2, and PAI3). 
Biofilms are often related with augmented resistance to antimicrobial agents and are 
usually associated with chronic infections, which are difficult to eradicate. Therefore, in 
this study, antibiotic susceptibility was tested and related with P. aeruginosa strains 
biofilm-forming ability. Results showed that an improved biofilm-forming ability does 
not seem to be related with biofilm resistance since the seven P. aeruginosa strains 
showed identical resistance and susceptibility profiles against ciprofloxacin and colistin, 
respectively, with the exception of PAI3 which exhibited higher resistance to 
ciprofloxacin. 
P. aeruginosa motility has been pointed out as a relevant factor for adhesion and 
biofilm development and also increased virulence. Thus, the swimming, swarming and 
twitching abilities of P. aeruginosa were evaluated. P. aeruginosa strains presented 
specific ability to move along surfaces. However, it was not found a clear relationship 
between higher motility and biofilm-forming ability and increased resistance. 
Similarly, slime production also contributes to biofilm development and is often implied 
in increased biofilm-resistance. Considering the results obtained, it was not found a 
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evident relationship between slime production and both biofilm-forming ability and 
increased resistance. 
The ability to produce and release extracellular toxins by P. aeruginosa is frequently 
related with higher levels of bacterial pathogenicity which can lead to severe 
consequences and even death. Among the several extracellular toxins, hemolysin and 
pyocyanin production were assessed in this study. Each P. aeruginosa strain displayed a 
different expression of these virulence factors. It was not possible to conclude if any P. 
aeruginosa strain was more virulent than other based only on these results. 
Phenotypic switching is an usual adaptive mechanism used by P. aeruginosa to increase 
their diversity and overcome exposure to stress conditions and environmental changes. 
Because colony morphology variation is the most visible characteristic of phenotypic 
switching, both planktonic and biofilm colonies were observed in order to establish 
where there is a relationship between bacterial mode of growth and colony morphology 
and also biofilm resistance. It was observed that phenotypic switching occurred when 
the P. aeruginosa strains changed their way of growth to biofilm-form. The rising of 
small-colony morphotypes was recorded for some P. aeruginosa strains (PAO1, ATCC 
10145, PA14, PAI1, and PAI3) when growing in biofilm-form, a morphotype usually 
associated with biofilm resistance. However it was not found a clear relationship with 
the rising of these small-colony variants and biofilm resistance and further studies are 
needed to better understand and establish the relationship of biofilm resistance and these 
morphotype variants. 
This work contributed to a further understanding of P. aeruginosa biofilm 
characteristics, including resistance features, virulence factors expression and 
phenotypic variation. It was concluded that there is not a general P. aeruginosa biofilm 
profile. Although resistance and susceptibility profiles against ciprofloxacin and 
colistin, respectively, of all strains were very similar, all virulence factors evaluated 
showed to be variable characteristic among all strains tested. In addiction it was not 
verified direct correlations between all virulence factors studied. Because there was 
recorded a variability in the virulence factors studied among all strains, no strain was 
considered more virulent than other given strain. 
Furthermore, results also show that there is an urgent necessity to reexamine the current 
clinical guidelines. These guidelines should regard phenotypic switching, intrinsic 
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responses of biofilms and virulence factors presented by P. aeruginosa biofilms, 
characteristics with therapeutical impact. 
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SUMÁRIO 
 
Ao longo dos últimos anos, vários estudos têm descrito que as bactérias demonstram 
uma maior resistência quando crescem em biofilmes. No entanto, as mudanças 
fenotípicas e os factores de virulência que apresentam e que se encontram associados 
com o aumento desta resistência são ainda pobremente compreendidos. 
O objectivo do presente estudo foi alargar o conhecimento acerca do aumento da 
resistência associada aos biofilmes de Pseudomonas aeruginosa e caracterizando 
fenotipicamente biofilmes formados por diferentes estirpes com o intuito de 
compreender se estes apresentavam um perfil de biofilme idêntico. P. aeruginosa é um 
agente patogénico oportunista muito comum que frequentemente se encontra associado 
a infecções persistentes que causam elevadas taxas de morbidade e mortalidade nos 
pacientes infectados devido à sua resistência intrínseca e à sua elevada resistência 
adaptativa a estímulos ambientais. 
A análise experimental consistiu na caracterização fenotípica de biofilmes, 
nomeadamente, a capacidade de formação de biofilme, susceptibilidade a antibióticos 
(ciprofloxacina e colistina), a expressão de vários factores de virulência e variação 
fenotípica. Para melhor replicar as condições reais este trabalho incluiu o estudo de 
várias estirpes de P. aeruginosa: quatro estirpes de referência (PAO1, ATCC 10145, 
CECT 111 e PA14) e três isolados clínicos (PAI1, PAI2 e PAI3). 
Os biofilmes encontram-se frequentemente associados com resistência aumentada a 
antimicrobianos e estão tipicamente relacionadas a infecções crónicas, muito difíceis de 
erradicar. Assim, neste trabalho, a susceptibilidade a dois antibióticos de uso clínico 
(ciprofloxacina e colistina) foi testada e relacionada com a habilidade de formação de 
biofilme das estirpes de P. aeruginosa de maneira a melhor compreender a resistência 
associada a biofilmes. No entanto, os resultados observados demonstraram que uma 
melhor habilidade de formação de biofilme não confere uma maior resistência a 
antibióticos, pois todas as estirpes de P. aeruginosa estudadas apresentaram perfis de 
susceptibilidade idênticos relativamente a ambos os antibióticos testados, com a 
excepção da estirpe PAI3 que revelou maior resistência à ciprofloxacina do que as 
restantes estirpes. 
A motilidade da P. aeruginosa tem sido apontada como um factor relevante para 
adesão, desenvolvimento de biofilme e virulência aumentada desta bactéria. Três tipos 
de motilidade comummente exibidos pela P. aeruginosa foram avaliados neste trabalho. 
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Todas as estirpes de P. aeruginosa estudadas apresentaram habilidades específicas de se 
mover ao longo de superfícies. No entanto, não foi estabelecida uma relação clara entre 
uma maior motilidade e habilidade de formação de biofilme e resistência aumentada. 
A produção de matriz (“slime”) está também envolvida no desenvolvimento do biofilme 
e muitas vezes é implicada na resistência aumentada a antimicrobianos. Considerando 
os resultados obtidos, não foi encontrada evidência que relacione a produção de matriz 
com formação de biomassa de biofilme e um aumento da resistência.  
A capacidade de produzir e libertar toxinas extracelulares pela P. aeruginosa é 
frequentemente relacionada com níveis mais elevados de patogenicidade que podem 
conduzir a graves consequências e ainda à morte do hospedeiro. Entre estas toxinas 
extracelulares foram estudadas as produções de hemolisina e piocianina. Cada estirpe de 
P. aeruginosa estudada demonstrou uma diferente expressão destes factores de 
virulência.  
A variação fenotípica é um mecanismo adaptativo muito comum utilizado pela P. 
aeruginosa para aumentar a sua diversidade e ultrapassar a exposição a condições de 
stress e mudanças ambientais. Como a variação da morfologia de colónias é a 
característica da variação fenotípica mais visível, foram observadas colónias formadas 
por células planctónicas e de biofilme com o objectivo de estabelecer se há uma 
correlação entre o modo de crescimento bacteriano e variação da morfologia de colónias 
e, até, resistência associada a biofilmes. Foi observado que, de facto, a variação 
fenotípica ocorria quando as estirpes de P. aeruginosa cresciam em biofilme. 
Relativamente à resistência associada a biofilmes, foi registado o aparecimento de 
pequenas colónias (small-colony variants) em algumas estirpes de P. aeruginosa 
(PAO1, ATCC 10145, CECT 111, PA14, PAI1 e PAI3), um morfotipo usualmente 
relacionado com a resistência associada a biofilmes. No entanto, não foi encontrada a 
relação entre o aparecimento destes morfotipos com a resistência associada a biofilmes 
e são necessários estudos adicionais para melhor entender e estabelecer a relação entre a 
resistência associada a biofilmes e estes morfotipos. 
Este trabalho contribuiu para uma melhor compreensão das características dos biofilmes 
formados pela P. aeruginosa, incluindo resistência, expressão de factores de virulência 
e variação fenotípica. Foi concluído que não existe um perfil de biofilme da P. 
aeruginosa universal. Apesar dos perfis de resistência e susceptibilidade contra a 
ciprofloxacina e a colistina, respectivamente, terem sido muito idênticos entre todas as 
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estirpes, todos os factores de virulência avaliados demonstraram ser características 
variáveis entre todas as estirpes estudadas. Para além disso, não foi verificada uma 
correlação directa entre todos os factores de virulência estudados. Devido à 
variabilidade encontrada na expressão dos diferentes factores de virulência estudados, 
nenhuma estirpe foi considerada mais virulenta do que outra. 
Em adição, os resultados demonstram que há uma necessidade urgente de rever as 
directrizes clínicas actuais. Estas directrizes devem ter em conta a variação fenotípica, a 
resposta intrínseca dos biofilmes e os factores de virulência expressos pelos biofilmes 
de P. aeruginosa, características que têm maior impacto a nível terapêutico.  
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GENERAL OUTLINE 
 
Until recent developments, acute infections were treated with antibiotics but these 
infections were not considered to involve biofilms[1] . Most of the infections that affect 
compromised hosts often comprise bacteria that are communal in the environment or are 
commensal with the human body such as Staphylococcus epidermidis and Pseudomonas 
aeruginosa[1]. 
Biofilm-associated infections display some similar clinical characteristics. These 
infections are characterized by persistent inflammation and tissue damage[2]. Bacterial 
biofilms consist of a community of cells enclosed in an exopolysaccharide matrix and 
attached to solid inert surfaces, such as medical devices, or in dead or living tissues[3]. 
These biofilms can be composed by single or many species.  
Infections associated with biofilms are often slow to manifest apparent symptoms[1] and 
are frequently related to hospital-acquired infections. When growing in biofilm forms 
bacterial cells can exhibit a 10-1000 times higher resistance to antimicrobial agents[3] 
and therefore biofilm-related infections are more difficult to eradicate. Given these 
evidences, it is clear that biofilms have a massive impact on medicine since they are 
associated with high patient morbidity and mortality and biofilm-based infections can 
increase costs linked with diagnostic and therapeutic practices. Therefore it is essential 
to rethink the current clinical guidelines and recognize the influence of biofilms in the 
treatment of infections. 
P. aeruginosa is one of the major microorganisms involved in urinary, bloodstream, 
pulmonary, soft tissue, and surgical site infections[4] in compromised individuals as 
those in intensive care units. These infections are also associated with increase 
morbidity and mortality and therapeutic possibilities are nowadays becoming limited 
due to the increased emergence of resistant strains[5]. 
This bacterium pathogenicity relies on its ability to easily adapt to diverse 
environmental conditions, expression of several virulence factors, and intrinsic 
resistance to several antimicrobial agents. Moreover P. aeruginosa pathogenicity can be 
increased when this bacterium grows under stress conditions and/or in biofilm form. 
Many processes for P. aeruginosa pathogenesis, antibiotic resistance and virulence, take 
place in the cell envelope and depend on components residing in the periplasmic space. 
Therefore, it is pivotal to analyze the phenotype of P. aeruginosa collected from 
different situations in order to identify some virulence and resistance factors of this 
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bacterium as well as characterize its biofilm-forming ability and recognize patterns of 
susceptibility to selected antibiotics. 
One of the main goals of this work is to deeply characterize virulence and antibiotic 
resistance profiles of P. aeruginosa cells recovered from biofilm in order to determine 
common features. In order to accomplish this goal biofilm-forming ability, 
susceptibility, slime production, production of extracellular toxins (hemolysin and 
pyocyanin), motility, and phenotypic switching of P. aeruginosa will be assessed.  
Ultimately, the impact of the P. aeruginosa characteristics studied on the therapy of 
infections caused by this bacteria will be discussed. 
This thesis is organized into four chapters. The first chapter reviews some significant 
aspects of P. aeruginosa biofilm formation and virulence factors and resumes the state 
of the art understanding the antimicrobial resistance in biofilm cells. Chapter 2 
summarizes the microorganisms, materials and methodology used in the experimental 
work. In Chapter 3 the results obtained in this study as well as the discussion of these 
results are presented. The final chapter involves the overall conclusions of the work 
presented in this thesis and suggests future research outline.
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CHAPTER 1. THE INFLUENCE OF PSEUDOMONAS AERUGINOSA RESISTANCE 
AND VIRULENCE IN CLINICAL ENVIRONMENTS 
This chapter resumes present knowledge on P. aeruginosa biofilm-associated virulence 
factors. Exceptional importance is given to biofilm resistance to antimicrobial agents, 
phenotypic variation, toxin production, and proteomic analysis of P. aeruginosa. 
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Bacteria growing in biofilm form are often the cause of chronic infections characterized 
by constant inflammation and severe tissue damage. Despite antibiotic treatment, 
biofilm-associated infections are difficult to eradicate and quite persistent causing high 
morbidity and mortality in compromised individuals. A vast number of bacterial species 
are known to cause these persistent infections (Table 1.1). 
 
Table 1.1 Some human infections associated with biofilms and the microorganisms causing them. 
(adapted from Costerton et al.[1]) 
Infection or disease Bacterial species 
Dental Caries Acidogenic Gram-positive cocci (e.g. Streptococcus) 
Periodontitis Gram-negative anaerobic oral bacteria 
Otitis media Nontypable strains of Haemophilus influenzae 
Musculoskeletal infections Gram-positive cocci (e.g. staphylococci) 
Necrotizing fasciitis Group A streptococci 
Biliary tract infection Enteric bacteria (e.g. Escherichia coli) 
Osteomyelitis Various bacterial and fungal species – often mixed 
Bacterial prostatitis E. coli and other Gram-negative bacteria 
Native valve endocarditis Viridans group streptococci 
Cystic fibrosis pneumonia P. aeruginosa and Burkholderia cepacia 
Meloidosis Pseudomonas pseudomallei 
Nosocomial infections  
ICU pneumonia Gram-negative rods 
Sutures Staphylococcus epidermidis and S. aureus 
Exit sites S. epidermidis and S. aureus 
Arteriovenous shunts S. epidermidis and S. aureus 
Schleral buckles Gram-positive cocci 
Contact lenses P. aeruginosa and Gram-positive cocci 
Urinary catheter cystitis E. coli and other Gram-negative rods 
Peritoneal dialysis peritonitis A variety of bacteria and fungi 
Intrauterine device Actinomyces israelii and many others 
Endotracheal tubes A variety of bacteria and fungi 
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Hickman catheters S. epidermidis and Candida albicans 
Central venous catheters S. epidermidis and others 
Mechanical heart valves S. aureus and S. epidermidis 
Vascular grafts Gram-positive cocci 
Biliary stent blockage A variety of enteric bacteria and fungi 
Orthopedic devices S. aureus and S. epidermidis 
Penile prostheses S. aureus and S. epidermidis 
 
Among these bacteria P. aeruginosa emerge as one of the microorganisms causing 
infection (Table 1.1). According to Hancock et al.[6], this bacterium is among one of the 
major opportunistic pathogens that origins hospital-acquired infections, causing up to 9-
10% of nosocomial infections. An intrinsic resistance and a high adaptive flexibility are 
the key mechanisms that contribute to P. aeruginosa subsistence. Because several 
strains of P. aeruginosa are becoming resistant to the antimicrobials traditionally used 
in the treatment of the infections caused by it, it is very important to understand the 
mechanisms that allow P. aeruginosa to cause these infections in order to establish new 
clinical guidelines for the treatment and eradication of P. aeruginosa related infections. 
For the reasons presented above, P. aeruginosa was selected for the development of this 
work among the several microorganisms that are known to cause biofilm-related 
persistent infections.  
 
1.1 BACTERIAL BIOFILMS 
 
Biofilms can be defined as organized communities of planktonic cells embedded in an 
extracellular exopolysaccharide matrix which is attached to an inert or living surface, 
such as medical devices[7, 8]. Biofilm formation is a complex process with a highly 
regulated development[9]. P. aeruginosa biofilm formation can be divided in five 
different stages (Figure 1.1): (i) reversible adhesion, (ii) irreversible attachment, (iii) 
microcolony formation, (iv) mature biofilm, and, ultimately, (v) dispersion[1, 10]. 
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Biofilm formation and development is initiated once bacterial cells attach irreversibly to 
the surface. As bacterial cells start to replicate and produce extracellular components 
biofilm starts to increase its complexity hence formatting microcolonies (Figure 1.1 
(iii)). Then biofilm differentiates and matures (Figure 1.1 (iv)), a stage characterized by 
its complex biofilm architecture[10]. The growth potential of the mature biofilm is 
restricted by numerous factors such as nutrient availability, nutrient perfusion within the 
biofilm, removal of waste products, and environmental physical and chemical 
conditions, such as pH, oxygen perfusion and osmolarity[11]. 
As soon as the biofilm reaches a dynamic equilibrium and critical mass, some cells may 
detach from the biofilm and may colonize other surfaces (Figure 1.1 (v)). This stage 
occurs due to marked activity and cellular differentiation in the center of the mature 
biofilm causing bacterial cells to disperse from within the biofilm, a process called 
“seeding dispersal”[12]. This process involves enzymes which degrade the 
exopolysaccharide matrix and death of cell subpopulations within the biofilm[13, 14]. It 
has been hypothesized that cell death disturbs biofilm architecture and living bacteria 
profit from nutrients released from the dead ones, aiding the change of surviving 
bacteria to the motile dispersal phenotype. 
All stages of biofilm development are controlled by bacterial population density gene 
expression regulated by quorum sense or cell-to-cell signaling molecules[15]. In P. 
aeruginosa two quorum sensing systems were identified: lasR-lasI and rhlR-rhlI. 
According to Davies et al.[16],  both quorum sensing systems are related to biofilm 
differentiation, although they are not connected to the initial phases of biofilm 
Figure 1.1 Stages of biofilm development. Stage (i) bacterial cells attach reversibly to the surface. Stage 
(ii) irreversal attachement. Stage (iii) microcolony formation. Stage (iv) maturation and diferentiation of 
the biofilm. Stage (v) dispersion of single motile cells from the cells. (adapted from Sauer et al[10]) 
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formation. Furthermore, Sauer et al.[12], suggested that physiologic changes as well as 
protein regulation alterations are also implied in biofilm development. 
 
1.2 PATHOGENESIS OF PSEUDOMONAS AERUGINOSA 
 
P. aeruginosa is a Gram-negative bacterium and, also, an opportunistic pathogen of 
plants, animals and humans[17, 18]. This bacterium is one of the leading cause of life-
threatening infections such as dermatitis, chronic wounds, urinary tract infections, 
severe burn infections, ocular infections and respiratory tract infections[17,19]. Also it is 
often related with the high morbidity and mortality infections in cystic fibrosis patients 
and immune compromised individuals. 
As an opportunistic pathogen, to initiate an infection, P. aeruginosa usually needs a 
substantial drop in the first line of the organism defenses[8]. This drop can have several 
backgrounds, such as alterations in the mechanisms of the immunologic system, a break 
in the mucosal or cutaneous barriers, or a disruption in the normal mucosal flora 
through the use of large spectrum antibiotics[20]. 
The pathogenicity of this bacterium is due to its ability to adapt phenotypically and to 
its high degree of genomic flexibility[18]. Moreover, this microorganism is able to 
augment its pathogenicity and virulence when exposed to stress conditions or when 
alternates its way of growth to biofilm. In the case of cystic fibrosis, the infected lungs 
provide a habitat where P. aeruginosa faces a diverse range of environmental barriers 
which cause morphologic modifications and forces its installation in specific niches[21]. 
When exposed to these conditions in the lungs, this bacterium assumes a mucoid form, 
this is, converts to a form that produces alginate exopolysaccharides at a large scale 
causing larger damages and a weak prognostic[22]. Therefore, similar to other bacteria 
species, such as Pseudomonas tolaasi[23], P. aeruginosa adapts its phenotype 
accordingly to regulatory environmental factors. 
Besides phenotypic adaptation, P. aeruginosa is known to exhibit an intrinsic resistance 
to antimicrobials. This characteristic holds in clinical environment severe consequences 
for treatment procedures and infection control. 
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1.3 VIRULENCE FACTORS 
 
This bacterium exhibits several virulence factors that are crucial to its pathogenesis. 
Production of extracellular enzymes and exopolysaccharides, low outer-membrane 
permeability, and motility are among some of the virulence factors produced by P. 
aeruginosa. Some of these aspects will have a special emphasis due to their importance 
in the upcoming results of this work. 
 
1.3.1 Biofilm Resistance 
 
P. aeruginosa antimicrobial resistance is due to a combination of several factors: this 
bacteria has an intrinsic resistance to antimicrobial agents due to a low outer-membrane 
permeability, it can become resistant trough mutations in its chromosomal genes 
responsible for the regulation of genes involved in resistance: it has a genetic ability to 
express a large repertoire of  resistance mechanisms and, ultimately, it can acquire 
resistance genes throughout plasmids, bacteriophages and transposons[24]. 
When growing in biofilm form, bacteria benefit from a distinctive type of resistance, 
which is different from the standard antimicrobial resistance mechanisms in P. 
aeruginosa, referred above. Biofilms exhibit not only resistance to antimicrobial agents 
but also to components of the host immune system. As a result, diseases that involving 
biofilms are usually chronic and difficult to eradicate[15]. 
Bacterial biofilms can often exhibit a resistance up to 1000 times higher to antimicrobial 
agents than planktonic bacteria[25], suggesting that some mechanisms associated with 
antimicrobial resistance of biofilms can differ from those involved in antimicrobial 
resistance in planktonic cells[15]. Therefore, infections associated with biofilms are 
difficult to eradicate with antimicrobial treatment and susceptibility tests in vitro have 
shown a considerable resistance to killing. 
Biofilm-associated resistance to antimicrobials (Figure 1.2) may be the outcome from 
several mechanisms: (i) bacterial cells grow very slowly due to oxygen and nutrient 
diminution within the biofilm; (ii) the physiology of the biofilm can be changed by 
intercellular signals, which can lead to the expression and overproduction of efflux 
pumps and augment biofilm resistance to a plurality of drugs; (iii) the negative charge 
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of the biofilm matrix neutralizes and damages antimicrobial agents, preventing them to 
reach the bacterial cells within the biofilm, this mechanism is denominated low outer-
membrane permeability; (iv) the antimicrobial concentration diminishes from the 
periphery to the center of the biofilm, impeding antimicrobial agents to kill bacterial 
cells localized within the biofilm; (v) genetic diversity contributes to the survival of 
some cells; (vi) induction of the general stress response and activation of quorum-
sensing systems can add to biofilm resistance; and (vii) the emergence of phenotypic 
and persister variants[15, 26]. 
 
Brooun et al.[27] demonstrated that, though most of the cells present in a biofilm of P. 
aeruginosa are effectively killed in low antibiotic concentrations, when raising the 
concentration of the antibiotic a small fraction of the cell population does not suffer 
death. Thus, the authors conclude that only a small fraction of the biofilm cells are 
related to its high resistance to antibiotics. Therefore, that study shows that, unlike 
planktonic cells where this small fraction of the cell population would be eliminated by 
the immune system, biofilm cells are protected by the matrix and this subpopulation of 
resistant cells can be responsible for the regrowth of the biofilm after antibiotic 
treatment. These cells are called persisters (Figure 1.3) and are not mutant[28]. 
In the same way, it is accepted that phenotypic variation of P. aeruginosa populations is 
intertwined with the resistance to high concentrations of antibiotics. Bacterial cells 
Figure 1.2 Numerous mechanisms comprised in P. aeruginosa biofilm-associated 
resistance. The increase of bacterial density within the biofilm (indicated by darkening 
colors) regulates gradients of nutrient and oxygen concentration (indicated by narrowing 
arrow). Reduced antimicrobial penetration is caused by the biofilm matrix (indicated by 
narrowing arrow). Resistance mechanisms may include the activation of quorum-sensing 
systems, general stress response and overexpression of efflux pumps. The emergence of 
biofilm-specific phenotypes, persisters and phenotypic variants is also a well-known 
resistance factor. (adapted from Drenkard et al[15]) 
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undergo phenotypic, physiologic and metabolic alterations soon after the adhesion to a 
surface[15]. Drenkard et al.[29] suggested that the presence of phenotypic variants in 
biofilms can be partially responsible for great levels of resistance to antimicrobials in P. 
aeruginosa biofilms. In the same study, a protein that controls the conversion between 
resistant and susceptible bacterial forms was identified. Therefore, the authors conclude 
that P. aeruginosa is able to experience transitory phenotypic alterations associated with 
its ability to form biofilms which allow it to increase its resistance to antibiotics both in 
vivo and in vitro. 
Although these two types of variants described represent a small fraction of the bacterial 
population that are able to ensure the persistence of P. aeruginosa biofilms throughout 
several cycles of antimicrobial treatment, persister cells only survive to killing by 
antibiotics[30] while phenotypic variants grow normally in presence of high levels of 
antibiotics[29]. Consequently, it is believed that different mechanisms are involved in the 
susceptibility changes experimented by both these variants[15]. 
 
1.3.2 Motility 
 
Motility can be considered one of the most interesting features exhibit by P. aeruginosa. 
This characteristic allows P. aeruginosa to move across different surfaces, permitting 
bacteria to establish pathogenic and symbiotic associations with the host[31]. Advantages 
of motility may include the aptitude to access ideal colonization niches within hosts, 
disperse in the environment, augment the nutrient uptake, and evade toxic substances 
released[31]. Bacterial motility can be classified into different types: (i) swimming, 
Figure 1.3 Schematic showing the resistance mechanism of 
persister/phenotypic variants. Antimicrobial treatment eradicates a great portion 
of biofilm susceptible population. A small fraction of resistant variants survives 
the antimicrobial treatment and is capable to re-start biofilme development 
once antimicrobial treatment is finished. (adapted from Drenkard et al[15]) 
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which allows bacteria to move across aqueous surfaces and is a flagellum-mediated type 
of motility; (ii) swarming, refers to bacterial movement on semisolid medium and is, 
also, flagellum-mediated; and (iii) twitching, which is a surface motility mediated by 
type IV pili and allows bacteria to move on solid environments[32-34]. 
Motility is known to be involved in biofilm development. In a former study, O’ Toole et 
al.[9] concluded that factors associated with bacterial surface, such as flagella and type 
IV pili, are essential to the P. aeruginosa biofilm development (Figure 1.4). 
 
Prior to attachment P. aeruginosa cells swim across the surface in order to find the best 
colonization site. Therefore flagellum-mediated motility is important to the initial 
attachment to the surface and to initiate the biofilm formation[7]. Swarming is a rapid 
movement across the surface, allowing bacteria to migrate and disperse to other sites, 
also, it is thought to be involved in protecting the pathogens against the host 
macrophages and is associated with secretion of toxins[35]. Type IV pili are essential 
adhesins that promote initial attachment to a surface. In addition there are evidence that 
in P. aeruginosa biofilms they are associated with both initial attachment and 
development of microcolonies[34]. In first stages of adhesion, microcolonies can also 
move across the surfaces throughout swarming motility promoting interactions with the 
surface and with each other. 
 
1.3.3 Slime Production 
 
One of the virulence factors known to several bacteria species is slime production. 
Some P. aeruginosa strains are also slime producers[37]. In other species such as 
Figure 1.4 Model for the role of flagella and type IV pili in biofilm formation. Flagella-
mediated motility is significant for the development of bacterial monolayer in the 
surface. Type IV pili are associated with initial attachment to the surface and 
microcolony formation. Flagella also seem to be connected to rapid movement of 
microcolonies which is imperative to protect the bacterial cells and bacteria migration.  
(adapted from O’ Toole et al[9])  
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staphylococci, slime production promotes its adherence to surfaces, facilitating biofilm 
development and survival[38]. 
As for P. aeruginosa, slime production seems to have a similar role as the ones 
described for different bacterial species, being essential in biofilm formation and 
resistance[39].  
The term slime can be explained as extracellular material or the biofilm matrix. Most 
biofilms are only comprised in less than 10% of dry mass while the matrix accounts for 
the remaining 90%[40]. The matrix is constituted by a conglomeration of different types 
of biopolymers in which biofilm cells are embedded and these are responsible for 
biofilm consistency and adhesion to surfaces[40]. Biofilm matrix also comprises a 
mixture of DNA, fatty acids, and proteins[41]. Of all biopolymers, exopolysaccharides 
have a noted importance since they represent a major fraction of the matrix[40]. 
P. aeruginosa produces at least three distinct exopolysaccharides that contribute to 
biofilm formation and architecture: alginate, Pel, and Psl[40, 42]. Alginate is one of the 
extendedly studied exopolysaccharides and it is involved in microcolonies formation in 
mucoid biofilms and responsible for mechanical stability of mature biofilms[40, 42]. Non-
mucoid strains produce Pel and Psl instead of alginate and both are involved in biofilm 
establishment. 
1.3.4 Production of Extracellular Toxins 
 
One of the virulence factors of P. aeruginosa is its ability to produce and release several 
extracellular toxins. These toxins include pigments, phytotoxic factor, phospholipases 
(hemolysins), proteolytic enzymes, enterotoxin, hydrocyanic acid, and exotoxin[36]. 
These extracellular toxins are often related to bacteria pathogenesis that can lead to 
severe consequences and even death of the host. Among those toxins, hemolysin and 
pyocyanin production will be described with more detail, due to their importance in the 
overall results of this work. 
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1.3.4.1 Hemolysin Production 
 
Hemolysin is one of the earlier extracellular toxin released by P. aeruginosa. Hemolytic 
activity in many bacteria is considered an important virulence factor and often 
contributes to bacteria pathogenicity. 
P. aeruginosa is known to produce two distinct types of phospholipases C (PLC’s). One 
of them is hemolytic (PLcHR) and the other nonhemolytic (PLcN)[43]. Consequently it 
is implied that PLcN has no pathogenic significance, while the production of PLcHR is 
a noted virulence factor. 
Hemolytic PLC has severe effects on the host. Several studies showed that clinical 
isolates from the lungs are able to produce phospholipase C and cystic fibrosis patients 
have circulating antibodies against PLC[44]. Also, PLcHR is capable of inducing 
leukotriene and thromboxane release from host cells, which can be an explanation for 
the inflammatory responses in P. aeruginosa infections[44]. 
In addition, the virulence associated with PLcHR seems to be connected to the 
suppression of neutrophil respiratory burst activity, suggesting that PLcHR is a 
significant toxin which facilitates pseudomonas survival in tissues despite the 
abundance of neutrophils[43]. 
 
1.3.4.2 Pyocyanin Production 
 
Pyocyanin is a blue-green phenazine-derived pigment produced by several P. 
aeruginosa strains[45]. Production of this pigment is seen as one of the most significant 
virulence factors exhibited by this bacterium[46].  
Pyocyanin exhibits a pro-oxidant propriety. Cellular respiratory inhibition is certainly 
the most significant toxic mechanism of pyocyanin against host cells[45]. Its ability to 
alter the redox cycle and increase oxidative stress appears to be the fundamental effects 
on host cells[45]. The increase of the oxidative stress will generate several consequences 
which depend on toxin concentration and time of exposure[46]. 
Lau et al.[47] reported that the production of pyocyanin by P. aeruginosa is critical in 
mice lung infections causing tissue damage and necrosis while the progression of the 
infection. In addition, Koley et al.[48] recently showed that when in biofilm pyocyanin 
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creates a redox potential gradient, called electroline, which increases iron availability, 
essential to biofilm development.  
 
1.3.5 Phenotypic Switching 
 
Bacteria are constantly confronted by environmental changes and adapting to these 
changes is vital to their survival. When these environmental alterations arise, a set of 
complex regulator mechanisms is activated allowing bacteria to survive. Often 
adaptation mechanisms include behavioral, physiological and genetic variations, as 
phenotypic variation[49]. 
Phenotypic switching or phase variation is considered to be a reversible switch between 
two phenotypic states. Usually it arises in a small fraction of biofilm population and is 
much more common than spontaneous mutations[49, 50]. Phenotypic switching is often 
used to increase population diversity and escape the host immunologic response[50]. 
Therefore, phase variation is translated in different expression of one or more genes 
resulting in two subpopulations: one subpopulation missing or having diminished level 
of phase variable gene(s) and the other expressing the gene completely[51]. A remarkable 
feature of phenotypic switching is the interchange between ‘On’ and ‘Off’ phenotypes. 
Meaning that bacteria can exhibit one of phenotypic states but keep the ability to switch 
to the other state[51] whenever different environment stimuli occur[49]. However, the 
event that results in this interchange is arbitrary because it is impossible to guess which 
bacterial cells will undergo the switch [51]. However several reports evidence that 
environmental signals and intercellular regulatory networks are involved on phenotypic 
switching mechanisms[49, 51, 52]. 
It is known that even in a homogeneous environment, isogenic bacterial population can 
display several phenotypes. This phenomena is called inherent phenotype heterogeneity 
and does not comprise changes in bacterial genes, it is a result of chemical reactions at 
DNA level, such as alterations in the rates of protein synthesis and degradation[49, 53]. 
One of the most visible characteristic of phenotypic switching is colony morphology 
variation[49]. Relationship between colony morphology and bacterial characteristics are 
yet to be understood. However colony morphology is very significant in the sense that 
its macroscopic observation can lead to which bacterial features were probably 
transformed and its connection with external stimuli[49]. In addiction, it can provide 
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information about the correlation between colony morphology, virulence, and 
antimicrobial resistance, which is valuable to plan new therapeutic approaches. 
Different kinds of colony morphotypes have been identified, such as small colony 
variants (sCV). These sCV are believed to be responsible for the increased virulence 
and resistance in P. aeruginosa strains[54]. Small colony variants (sCV) have been 
involved in persistent and recurrent human infections[49], for example sCV have been 
isolated from the respiratory tract of patients infected with cystic fibrosis[54] and medical 
devices. For P. aeruginosa a sCV is defined as a colony with a diameter of 3 mm or 
less. 
In bacteria that grow in biofilm, different colony morphotypes have also been identified 
and phenotypic heterogeneity within biofilms is considered one of the main reasons of 
biofilm resistance[49]. However, this is still a recent study field and is yet to be 
completely understood. Biofilm-colony diversity is affected by the stage of biofilm 
development and the proportion of each colony morphotypes is influenced by external 
factors, showing evidence that these morphotypes are highly connected to mechanisms 
in biofilm establishment and biofilm survival, increase tolerance to antimicrobials and 
other stress factors[49, 55, 56]. 
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CHAPTER 2. MATERIALS AND METHODS 
In this Chapter, the methods and techniques utilized in the present study are described. 
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2.1 BACTERIAL STRAINS 
 
In the present study a total of seven strains of P. aeruginosa were used. Among these 
strains, four were reference strains (PAO1, ATCC 10145, CECT 111, and PA14) and 
three clinical isolates (PAI1, PAI2, and PAI3). All strains were routinely cultured on 
Trypic Soy Broth (TSB, 30 g/L, Liofilchem) or Trypic Soy Agar (TSA; agar, 15 g/L, 
Liofilchem; TSB, 30 g/L, Liofilchem) and incubated at 37°C. Bacteria were preserved 
in criovials at -80 ± 2°C. Before each experiment, bacteria were grown on TSA plates 
for 24h at 37°C. 
 
2.2 BIOFILM FORMATION 
 
The ability of P. aeruginosa to form biofilm was performed as previously described[7, 
57]
. P. aeruginosa strains were grown overnight on TSB at 37°C under agitation (120 
rpm). Cell suspension was diluted in order to obtain the final concentration of  1 × 10 
CFU/mL. Lastly, the 96-well microtitre plates were inoculated with 200 µL of the 
adjusted cellular suspension per well. After inoculation, plates were incubated 
aerobically at 37°C for 24 h under agitation (120 rpm). 
After biofilm formation, the content of the plates was discarded and they were washed 
twice with sterile water in order to remove weakly attached cells and cell products 
which were in suspension. To remove biofilm-cells from the biofilm matrix, plates were 
subjected to an ultrasonic bath for 6 minutes. 
 
2.3 QUANTIFICATION OF BIOFILM FORMATION 
 
P. aeruginosa strains biofilm formation was quantified by crystal violet (CV)[57]. 
Biofilms in 96-well microtitre plates were washed twice with sterile distilled water to 
remove unattached or weakly attached bacteria. Afterwards 200 µL per well of 
methanol  were added and plates were allowed to stand for 15 minutes in order to fix the 
biofilm-cells to the walls of the well. Then, methanol was discarded and plates were left 
to dry for 5 minutes at room temperature. Biofilms were stained with 200 µL of pure 
CV () and plates were incubated at room temperature for approximately 5 minutes. 
Then, plates were rinsed thoroughly and repeatedly with tap water. Finally, the amount 
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of biofilm formed was quantified by solubilization of the CV in 200 µL of acetic acid 
(33% v/v). The optical density (OD) was measured at 570 nm using a microtiter plate 
reader (Tecan (Sunrise-Basic Tecan), Austria). 
 
2.4 QUANTIFICATION OF THE NUMBER OF VIABLE BIOFILM-CELLS 
 
The number of viable cells obtained from biofilms was inferred through colony-forming 
unit (CFU). Cell suspensions obtained from biofilm removal were serial diluted, plated 
on TSA, and incubated overnight at 37 °C. 
 
2.5 SUSCEPTIBILITY TESTING 
 
Susceptibility of P. aeruginosa biofilm-cells was evaluated determining the minimum 
inhibitory concentration (MIC) and the minimum bactericidal concentration (MBC). 
The antibiotics ciprofloxacin and colistin were used and purchased from Fluka and 
Sigma, respectively. Ciprofloxacin and colistin were employed in the current study 
because they are both used in the treatment of P. aeruginosa infections. 
The MIC values were determined according to standard European Committee on 
Antimicrobial Susceptibility Testing (EUCAST) through broth microdilution 
method[58]. The optical density at 640 nm of bacterial suspension was measured in order 
to adjust the cellular concentration to 10 × 10 CFU/mL. To maintain viable cell 
number concentration plates were inoculated within 30 minutes of standardizing the 
bacterial suspension. Working antibiotic solutions (diluted antibiotic in broth) were 
dispensed into plates at 50 µL per well with double of the desired final concentration. 
To each well containing 50 µL of diluted antibiotic agent in broth a volume of 50 µL of 
inoculum suspension was added. One of the wells only contained 100 µL of Mueller-
Hinton (MHB, 22 g/L, Fluka) broth (antibiotic-free medium) to work as a negative 
control. Therefore, the final inoculum concentration was 5 × 10 CFU/mL. Plates were 
incubated overnight at 37°C under agitation (120 rpm). 
For determination of MBC values, 10 µL were removed from the wells of the 
microdilution trays after incubation and were plated in TSA plates and incubated at 37 
°C for 24 h. 
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2.6 MOTILITY TESTS 
 
Optical density of the biofilm-cell suspension was measured at 640 nm so that the final 
concentration would be 1 × 10 CFU/mL. Swimming, swarming and twitching motility 
assays were performed in TSA plates with agar concentration of 0.3 %, 0.5% and 1.5% 
(w/v), respectively. Plates were inoculated with 1 µL of cellular suspension and then 
incubated at 37 °C for 24 h. After incubation the circular turbid zone formed by the 
bacterial cells migrating away from the point of inoculation was measured in 
millimeters. 
 
2.7 SLIME PRODUCTION ASSAYS 
 
To determine whether P. aeruginosa cells collected from biofilms produced slime, 
Brain Heart Infusion (BHI, 37 g/L, Liofilchem) with Congo Red (0.8 g/L, Sigma) plates 
were used. Afterwards, optical density at 640 nm was measured in order to adjust the 
bacterial suspension to the final concentration of  1 × 10 CFU/mL. Then, BHI plates 
were inoculated with 1 µL of inoculum and incubated overnight at 37 °C. 
The strong slime producers usually result in really dark colonies (almost black) with a 
dry crystalline consistency whereas the negative result was showed by almost pink 
colonies. Sometimes these pink colonies revealed darkening centers and these colonies 
indicated an intermediate result. 
 
2.8 EXTRACELLULAR TOXINS PRODUCTION 
 
 
2.8.1 Hemolysis Assays 
 
Resembling the previous assay, hemolytic activity of cells derived from P. aeruginosa 
biofilms was assessed using Columbia Agar (CA; agar, 15 g/L, Liofilmchem; Columbia 
broth, 43 g/L, Liofilchem) with sheep blood plates. Optical density at 640 nm was then 
measured to regulate the biofilm-cell suspension to the final concentration 1 × 10 
CFU/mL. Lastly, CA with blood plates were inoculated with 1 µL of cellular suspension 
and incubated overnight at 37 °C. 
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2.8.2 Pyocyanin Quantification 
 
Pyocyanin levels were determined using a previously described[59] quantitative chemical 
assay. Bacteria of P. aeruginosa planktonic and biofilm cultures were pelleted at 13000 
rpm for 10 minutes. Then, 750 µL of cell-free supernatants containing pyocyanin were 
collected and mixed with the same amount of chloroform. Samples were mildly 
vortexed and centrifuged at 13000 rpm for 1 minute. Afterwards the inorganic phase 
was removed and 750 µL of 0.2M HCl (Panreac) was added to the organic phase. 
Samples undergone a brief vortexing and were centrifuged at 13000 rpm for 1 minute. 
After centrifugation the pink layer was collected and its optical density was measured at 
520 nm. Ultimately, the pyocyanin concentration was determined multiplying the OD520 
values with17.072 and results were expressed in µg/mL. 
 
2.9 PHENOTYPIC CHARACTERIZATION OF BIOFILM-CELLS AND PLANKTONIC 
CELLS 
 
To assess biofilm population diversity, bacteria derived from biofilms were serial 
diluted and plated on TSA and grown at 37 °C for 48 h. Colonies were observed by 
directly placing the petri plates under a magnifying glass (Olympus SZ-CTV) and 
photographed with a CCD camera (AVC, D5CE; Sony, Tokio, Japan). Each colony 
morphology identified was classified using ten parameters: form, margin, surface, 
texture, sheath, opacity, elevation, size, color and diameter (Appendix A). A phenotypic 
variant was considered when it differed in at least one of the referred morphological 
parameters. 
 
2.10 STATISTICAL ANALYSIS 
 
Statistical analysis was performed using GraphPad Prism, version 5.0. Statistical 
significance values of the groups’ means of biofilm quantification, number of viable 
biofilm-cells, swimming, swarming, twitching and biofilm and planktonic pyocyanin 
were evaluated using one-way ANOVA. Following comparisons were performed using 
Turkey’s test. Statistical analyses performed were considered significant when p < 0.05. 
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CHAPTER 3. RESULTS AND DISCUSSION 
This Chapter displays the experimental results, observations, and remarks about these 
results.   
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In this study seven P. aeruginosa strains were tested. Among these four were reference 
strains (PAO1, CECT 111, ATCC 10145, and PA14) and three were clinical isolates 
(PAI1, PAI2 and PAI3). Ability to form biofilm, expression of several virulence factors, 
and antibiotic susceptibility were evaluated for all of the strains. 
  
3.1 QUANTIFICATION OF BIOFILM FORMATION 
 
 
The biofilm formation ability of P. aeruginosa strains is shown in Figure 3.1. 
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Figure 3.1 Biofilm mass (OD570) of P. aeruginosa strains used in this work. Bars represent the average of 
four independent repeats ± SD. 
 
It can be observed that PAO1 was the P. aeruginosa strain that formed the larger 
amount of biofilm biomass (p <0.05), in contrast with PA14 that formed the lowest 
quantity of biofilm biomass (p <0.05). Although is noted that PAO1 strain produced a 
larger biofilm biomass, differences between the quantity of biofilm biomass formed by 
this strain and CECT 111 and ATCC 10145 strains were not statistically significant (p 
>0.05). In fact, only the differences of biofilm biomass produced by PAO1 strain and 
PA14, PAI1, PAI2, and PAI3 strains were found to be statistically significant (p  <0.05). 
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Concerning the amount of viable cells recovered from biofilms (Figure 3.2), it was 
noted that all P. aeruginosa strains formed biofilms with equal number of cells (p 
>0.05). 
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Figure 3.2 Number of viable biofilm-cells of P. aeruginosa strains used in this work. Bars represent the 
average of three independent repeats ± SD. 
 
Taking into account data related to biofilm biomass quantification and number of viable 
cell, it is hypothesized that the amount of viable cells does not seem to influence the 
amount of biofilm biomass that each P. aeruginosa strain is able to form.  
It is well known that biofilms are the favored mode of bacterial growth in nature and 
infectious diseases[60]. Biofilms are three-dimensional structures in which bacteria are 
imbedded in a polysaccharide matrix, protein, and DNA[60]. Thus, it is understandable 
that the amount of viable cells is just one of the many components that may contribute 
to the biofilm formation ability of P. aeruginosa. In this study, evidence that the amount 
of viable cells does not seem to be a relevant factor for the formation of biofilm was 
shown. Although all P. aeruginosa strains had similar amounts of viable cells, their 
biofilm formation ability was quite different among some strains. Therefore, the ability 
to form biofilms by P. aeruginosa must comprise other mechanisms, such as the cells 
capability to form the matrix components. 
It is important to add that the crystal violet assay offers information about the adhesion 
of P. aeruginosa strains to a non-biological material. Therefore it can provide 
information about their adhesion onto medical devices, such as catheters, in which this 
bacterium can form biofilm leading to nosocomial and chronic infections[39]. It can be 
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concluded that PAO1 is the P. aeruginosa strain which represents higher risk to cause a 
nosocomial and chronic infection. This fact emphasizes that the ability to form biofilm 
is only one of the factors involved in the development of a P. aeruginosa infection 
however when dealing with these infections this is only one of the virulence factors to 
be considered among several that can be exhibit by P. aeruginosa. 
 
3.2 VIRULENCE CHARACTERIZATION OF BIOFILM-CELLS 
 
Biofilm-cells were subjected to an extensive phenotypic study in order to compare the 
expression of virulence factors of P. aeruginosa. Virulence factor expression is 
determinant for the success of P. aeruginosa survival in human environment. The 
display of these virulence factors allows P. aeruginosa to adapt to several host 
environments and to colonize different kinds of niches, being extremely important to the 
pathogenesis of this bacterium. Among the virulence factors exhibited by P. aeruginosa 
some can be enhanced like low outer-membrane permeability, motility and production 
of exopolysaccharides and extracellular enzymes. Some of these factors will be 
thoroughly studied in this work.  
 
3.2.1 Susceptibility testing of biofilm-cells 
 
Currently, the range of traditionally used antibiotics against pseudomonal infections 
includes ticarcillin, aminoglycosides, ceftazidime, carbapenems (with the exception of 
ertapenem), ureidopenicillins, aztreonam, cefepime, ciprofloxacin and levofloxacin[61]. 
In the present study, two antibiotics were chosen to perform the susceptibility tests: 
ciprofloxacin, an empirical therapy for P. aeruginosa infections, and colistin, a last-
resort therapeutic option for such infections due to its severe toxicity[61]. 
Ciprofloxacin belongs to the fluoroquilonone drug class[6]. Ciprofloxacin is known to be 
particularly effective against gram-negative bacteria. Its action mechanism includes the 
inhibition of DNA replication and possibly transcription [62].  
Colistin belongs to the polymyxins class[6]. Polymixins are positive charged and cyclic 
peptides antibiotics resultant from several species of Paenibacillus polymyxa. This 
antibiotic class action mechanism comprises the disruption of the cellular membrane 
resulting in outflow of intracellular components. 
  
23 
 
Phenotypic profiling of several strains of Pseudomonas aeruginosa: identification of potential virulence factors 
MICs and MBCs were determined concerning the two antibiotics of clinical use (Table 
3.1). P. aeruginosa strains were classified into two classes according to the EUCAST 
clinical breakpoints: susceptible (S) if MIC was lower than the clinical breakpoint and 
resistant (R) if MIC is found to be higher than the clinical breakpoint. 
 
Table 3.1 Minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) 
values of ciprofloxacin (CIP) and colistin (COL) against P. aeruginosa strains. S stands for susceptible 
strain and R stands for resistant strain according to the EUCAST clinical breakpoints. EUCAST clinical 
breakpoints (mg/L): (i) ciprofloxacin: S ≤ 0.5 and R > 1; (ii) colistin: S ≤ 4 and R > 4. 
Strain 
MIC 
(mg/L) 
MBC 
(mg/L) 
COL CIP COL CIP 
PAO1 2 S 4 R 16 8 
CECT 111 2 S 4 R 16 8 
ATCC 10145 2 S 4 R 8 8 
PA14 2 S 4 R 16 8 
PAI1 2 S 4 R >16 16 
PAI2 2 S 4 R 8 >16 
PAI3 2 S 8 R >16 >16 
 
All P. aeruginosa strains were found to be susceptible to colistin and resistant to 
ciprofloxacin. MIC value was found to be highest for ciprofloxacin (4 and 8 mg/L) and 
lowest for colistin (2 mg/L). All strains showed the same level of susceptibility against 
colistin. However PAI3 strain was found to be the most resistant strain among those 
used in this study (8 mg/L) against ciprofloxacin. Therefore, and since colistin 
susceptibility was the same for all strains studied, this strain was considered the most 
resistant P. aeruginosa strain studied. 
Concerning the MBC values, the lowest and highest values registered was equal for 
both antibiotics 8 mg/L and >16 mg/L, respectively. Against colistin, PAI1 and PAI3 
strains were the P. aeruginosa strains that showed highest MBC values (Table 3.1). On 
the other hand, against ciprofloxacin, PAI2 and PAI3 were the strains that registered the 
highest MBC values (Table 3.1). Although some differences were noted, it can be said 
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that P. aeruginosa strains have similar MBC values because these values had only a 
four-fold maximum difference between them. 
Given these results, it can be said that the administration of ciprofloxacin to control and 
eradicate P. aeruginosa biofilm-cells is actually ineffective. Therefore, it is important to 
replace the use of ciprofloxacin as an empirical therapy for P. aeruginosa infections. 
It is also essential to remark that although pseudomonal infections seem very similar, 
the bacterial strain causing them can exhibit quite different antibiotic susceptibilities. 
Therefore, prescribing the same antibiotic treatments to patients revealing analogous 
symptoms may not be the correct methodology[61]. Sampling the local of infection in 
order to identify the pathogenic agent can be one of the solutions for this problem. 
However, a delay on the therapeutic treatment increases patient mortality hence 
antibiotic therapy should not wait for the sampling results. 
Due to their action mechanism, polymyxins are sheltered from cross-resistance with 
other antimicrobial agents and protected from the rapid selection of resistance[61]. 
Therefore it is understandable that all P. aeruginosa strains show susceptibility against 
colistin. Hence, using colistin as a therapeutic treatment for P. aeruginosa related 
infections can be more effective than using ciprofloxacin. However to verify this 
hypothesis in vivo testing should be performed. Also, colistin features high toxicity 
including nephrotoxicity and neurotoxicity[61] and its prescription should only be an 
option when other therapeutic alternatives have run out. 
 
3.2.2 Motility Tests 
 
It is known that P. aeruginosa exhibits different types of motility when growing in 
environments with different compositions and viscosity[32]. The most characterized in 
literature are swimming in aqueous medium, swarming on semisolid environments and 
twitching on solid surfaces[32].  These three types of motility were evaluated for all 
seven strains of P. aeruginosa used (Figures 3.3, 3.4, and 3.5). All P. aeruginosa strains 
tested shown to possess all the three different forms of motility. 
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3.2.2.1 Swimming 
 
Swimming allows bacteria to move in liquid surfaces and is mediated by flagellum. 
Also swimming motility is one of the most important factors to the initial attachment of 
P. aeruginosa cells to surfaces upon biofilm mode of growth[19]. Therefore, swimming 
motility is greatly essential for the effective development of biofilms.  
The results of this experiments are shown in Figure 3.3 and were found to be 
statistically significant (p <0.05) and all P. aeruginosa strains presented the ability to 
swim. 
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Figure 3.3 Diameter of the swimming migration zone formed by P. aeruginosa strains. Symbols 
represent the average of three independent repeats ± SD.  
 
Because swimming motility is involved in the initial attachment of P. aeruginosa cells 
to surfaces, it was expected that the P. aeruginosa strains found to form higher amounts 
of biofilm biomass (Figure 3.1) would be the ones that registered greater swimming 
migration zones as well. However, evidence found in this study contradicts this 
hypothesis. Actually, PA14 strain and the clinical isolates PAI2 showed larger 
swimming migration zone diameters (Figure 3.3) in comparison with the remaining 
strains studied (p <0.05). However, these strains formed lower amounts of biofilm 
biomass (Figure 3.1).  In comparison, it was observed that P. aeruginosa strains that 
formed larger amounts of biofilm (Figure 3.1) showed smaller swimming migration 
zone diameters (Figure 3.3) like PAO1, CECT 111, and ATCC 10145.  
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These findings led to the hypothesis that, although swimming motility has a huge role in 
developing biofilms, its importance must be crucial only at an initial stage of biofilm 
formation and not throughout all phases of biofilm formation. Therefore, it can be said 
that that swimming translates the adhesion ability of the cells instead of their biofilm 
formation ability.  In fact, swimming motility assays were performed with biofilm-
derived cells recovered from biofilms after 24 hours of biofilm formation and not in an 
initial stage. To better understand the role of swimming motility in P. aeruginosa 
biofilm development, swimming motility assays should be executed in an early stage of 
biofilm formation or even in planktonic cells. 
  
3.2.2.2 Swarming 
 
Swarming is flagella-mediated type of motility and is defined as a quick and 
coordinated multicellular movement across a semi-solid surface[33]. The results of these 
experiments are presented in Figure 3.4. 
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Figure 3.4 Diameter of the swarming migration zone formed by P. aeruginosa strains. Symbols represent 
the average of three independent repeats ± SD. 
 
Concerning swarming motility, PA14, PAI2, and PAI3 (p <0.05) were the P. 
aeruginosa strains that showed swarming rings with the larger diameters while the 
remaining strains formed the smaller rings (Figure 3.4). The differences between the 
diameters of PAO1, CECT 111, ATCC 10145, and PAI1 strains swarming migration 
zone were not found to be significant (p >0.05).  
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Swarming is a type of social motility characterized of some degree of cellular 
differentiation and regulation through cell-to-cell communication usually named “social 
phenomena”[33]. Swarming allows rapid colonization of surfaces by highly differentiated 
swarm cells. Swarming motility has been associated with resistance to several 
antimicrobials[63]. According to Lai et al[33]  this multiresistant characteristic of swarm 
cells is also applicable to P. aeruginosa. 
Given this evidence, it was expected that strains that formed larger swarming migration 
zones (Figure 3.4) would be more resistant to the antibiotics used in this study. 
However, based on the results this hypothesis was not confirmed since all P. aeruginosa 
strains showed very similar resistance profiles against ciprofloxacin and equal 
susceptibility profiles against colistin. And, for instance, PAI3 strain considered the 
most resistant against ciprofloxacin (Table 3.1) was not the strain that developed greater 
swarming migration zones.  
As swarming-associated resistance is a transient resistance this means that this kind of 
resistance is unstable and can be lost[33] and, also, swarm cells develop a resistant 
phenotype as a result of cell differentiation and not in response to antibiotic stress[33]. 
This can explain why the strains that developed greater swarming zones were not the 
ones found to be more resistant to both antibiotics tested. To better understand the 
relationship between resistance and swarming-cells susceptibility tests should be 
performed with swarming-cells instead of biofilm-cells. 
 
3.2.2.3 Twitching 
 
Twitching motility is mediated by type IV pili, it consists in a slow bacteria movement 
and plays an important role in the development of the biofilm architecture[34].  
The results of this experiments are shown in Figure 3.5, these were found to be 
statistically significant (p <0.05) and all P. aeruginosa strains tested displayed the 
ability to twitch. 
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Figure 3.5 Diameter of the twitching migration zone formed by P. aeruginosa strains used in this study. 
Symbols represent the average of three independent repeats ± SD. 
 
According to Figure 3.5, PA14 strain showed larger twitching migration zones. The 
three other reference strains (PAO1, CECT 111, and ATCC 10145) showed the smallest 
of the migration zone diameters as well as one of the clinical isolates (PAI1). Although 
some differences were noted, besides PA14 strain, and agreeing to Figure 3.5, all P. 
aeruginosa strains showed close migration zone diameters values. 
Type IV pili are thought to be implicated in a direct role in stabilizing interactions with 
the abiotic surface and/or cell-to-cell interactions necessary to form a microcolony[9]. 
Taking into account these facts it is understandable that twitching motility contributes to 
biofilm formation and strains which exhibit the larger twitching migration zone 
diameters were expected to be great biofilm-forming strains since cell-to-cell and/or 
cell-to-surface interactions would be more cohesive. In this study, evidence show the 
opposite, PA14 strain showed the larger twitching migration zone diameter but it was 
the P. aeruginosa strain that formed the least amount of biofilm biomass (Figure 3.1) 
while strains with greater biofilm-forming ability, such as PAO1, CECT 111, and 
ATCC 10145 (Figure 3.1), displayed smaller twitching migration zone diameters. These 
results suggest the presence of unidentified and additional adhesions that promote cell-
to-surface interactions besides type IV pili. 
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3.2.3 Slime and Extracellular Toxins Production 
 
3.2.3.1 Slime Production Assays 
 
One of the virulence features known to several bacteria species, including P. 
aeruginosa, is slime production[37]. Slime production promotes its adherence to 
surfaces, facilitating biofilm development and survival[38,39]. 
To evaluate slime production of cells obtained from biofilms of all P. aeruginosa 
strains, a qualitative method that consists in spreading biofilm-cells in BHI agar plates 
was used. The results obtained are outlined in Table 3.2. 
 
Table 3.2 Classification of slime and hemolysin production of P. aeruginosa strains. 
Strain Slime Production 
PAO1 Negative 
CECT 111 Negative 
ATCC 10145 Negative 
PA14 Moderate 
PAI1 Strong 
PAI2 Moderate 
PAI3 Moderate 
 
P. aeruginosa strains were classified into three different categories according to the 
intensity of the red color of the P. aeruginosa colonies obtained on BHI agar plates: 
“negative” if the color of the colonies was the same as the medium, “moderate” if the 
color of the colonies was slightly darker than the medium, and “strong” if the color of 
the colonies was much darker than the medium (Figure 3.6).  
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Using these criteria, the slime production of three of the strains PAO1, CECT 111, and 
ATCC 10145 was considered negative, two clinical isolates (PAI2 and PAI3) and strain 
PA14 demonstrated to have moderate slime production and, finally, only one strain 
PAI1 showed a strong slime production (Table 3.2). 
It has been reported that P. aeruginosa strains are slime producers. In a study aiming to 
evaluate biofilm production by uropathogens isolated from patients with urinary 
infections, Niveditha et al.[37] isolated among fifty strains two P. aeruginosa strains and 
both strains were slime producers. 
According to Freeman et al.[38], the production of slime of coagulase negative 
staphylococci may benefit their adherence to biopolymers and also be accountable for 
reduced therapeutic response and relapse. The authors also stated that the production of 
slime may be associated with inhibition of the immune response. The production of 
slime by P. aeruginosa has a similar role to the one described by Freeman et al.[38]. It is 
known that this bacterium produces a great amount of exopolysaccharides and these 
besides being associated with biofilm formation are also implied in protecting this 
species against the complement system, mucociliary, phagocytosis and reduced 
antimicrobial activity since it makes the penetration in the bacterium demanding[39]. 
Although it is thought that strains that produce larger slime amounts are less susceptible 
to antibiotic stress, given that in this study all P. aeruginosa strains showed identical 
resistance profile against ciprofloxacin and an equal susceptibility profile against 
colistin, it is tempting to infer that slime production does not seem to be implied as a 
resistance mechanism or this hypothesis is not applicable in the case of ciprofloxacin 
and colistin. 
A B 
A1 A2 B1 B2 
Figure 3.6 Slime Production Assay. A: BHI agar plate demonstrating the difference between negative 
(A1) and moderate (A2) slime production. B: BHI agar plate representing the difference between 
moderate (B1) and strong (B2) slime production.  
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Also, it was expected that the strains with a stronger ability of slime production were the 
ones capable of producing greater amounts of biofilm biomass. Based on the results 
referring to quantification of biofilm biomass (Figure 3.1), it is correct to conclude that 
the slime production ability does not have such a linear connection with biofilm-
forming ability. For instance, PAO1, CECT 111, and ATCC 10145 were the strains 
considered able to form greater amounts of biofilm biomass (Figure 3.1) and were their 
slime production ability was considered negative (Table 3.2). 
Several researchers use this method as a technique to quantify bacteria biofilm-forming 
ability. In a study comparing three different methods for detection of biofilm formation 
in Staphylococci clinical isolates, two of them being the CV and the BHI with Congo 
Red, Mathur el al.[64] found that the BHI with Congo Red method showed a very poor 
correlation with the two other methods. In the same study the authors also conclude that 
the BHI with Congo Red had a low sensitivity and accuracy[64]. In the present study, 
discrepancies between the two methods were also found. Based on the data obtained, it 
is not recommended to use the BHI with Congo Red method to evaluate the biofilm-
forming ability of P. aeruginosa. Opposing the CV method, the BHI with Congo Red is 
a qualitative and visual technique, which depends on individual interpretation. However 
it provides truthful and useful information about the amount of slime produced while 
bacteria form the biofilm and is a simple and reproducible method. 
 
3.2.3.2 Hemolysis Assays 
 
Because hemolysins produced by several bacteria are recognized to contribute to their 
virulence, the hemolytic activity of the P. aeruginosa strains was also characterized in 
this study. Results obtained are presented in Table 3.3. 
It is known that P. aeruginosa produces two different kinds of phospholipases C 
(PLC’s): one being hemolytic (PLcHR) and the other nonhemolytic (PLcN)[43]. 
Therefore, while PLcN has no pathogenic significance, PLcHR is accepted as one of the 
most important virulence factors that can be expressed by P. aeruginosa[43]. 
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Table 3.3 Classification of hemolysin production of P. aeruginosa strains. 
Strain Hemolysin Production 
PAO1 Positive 
CECT 111 Negative 
ATCC 10145 Positive 
PA14 Positive 
PAI1 Positive 
PAI2 Positive 
PAI3 Positive 
 
To determine the hemolytic activity of P. aeruginosa cells derived from biofilms were 
spread onto Columbia agar plates with blood and results were recorded as following: 
“negative” if the culture medium maintained its appearance and “positive” if the culture 
medium around the P. aeruginosa colonies became translucent, indicating lysis of the 
blood cells present in the culture medium (Figure 3.7). According to data obtained 
(Table 3.3) all strains with the exception of reference strain CECT 111 exhibited 
hemolytic activity. 
These results showed that probably only CECT 111 strain is unable to produce PLcHR. 
All the other strains express one of the most virulent aspects of P. aeruginosa. 
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Hemolytic PLC was associated with increased vascular permeability, organ damage, 
and even death when injected into mice according with previous studies[65]. Also, 
several studies reported that PLC’s have proinflammatory activity in vitro and in 
vivo[65]. 
Therefore, considering only these results, all P. aeruginosa strains can be considered 
more virulent than CECT 111 strain when involved in infections since the hemolytic 
activity showed by these strains can lead to devastating consequences to the host’s 
immune system and even to organ damage and death. 
3.2.3.3 Pyocyanin Quantification 
 
It is known that some P. aeruginosa strains are able to produce a blue-green pigment 
named pyocyanin. Pyocyanin is responsible for increasing oxidative stress and alter the 
redox cycle on host cells[45]. Also pyocyanin is able to disturb the cellular respiration 
and inhibit epidermal cell growth[45]. Therefore it is nowadays considered one of the 
most relevant virulence factors that a P. aeruginosa strain can exhibit. 
In order to quantify the amount of pyocyanin produce by the P. aeruginosa strains, for 
both planktonic and biofilm cells, a chemical assay was performed and the amount of 
pyocyanin present in the supernatant was quantified. 
The results of these experiments are presented in Figure 3.8 and Figure 3.9. 
Figure 3.7 Hemolysis Assay. Blood agar plate demonstrating the 
nonhemolytic activity of PlcN (A) and hemolytic activity of PlcHR 
(B). 
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Figure 3.8 Amount of pyocyanin produced (OD520) by P. aeruginosa planktonic cells. Bars represent the 
average of four independent repeats ± SD. 
 
The results obtained for pyocyanin quantification for P. aeruginosa planktonic cells 
were found to be statistically significant (p <0.05). For planktonic cells, the P. 
aeruginosa strain that produced a larger amount of pyocyanin was PA14 strain, 
followed by the clinical isolate PAI2 (Figure 3.8). The remaining strains showed similar 
amounts of production of this pigment (p >0.05) and this amount was not considered 
significant. 
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Figure 3.9 Amount of pyocyanin produced (OD520) by P. aeruginosa biofilm cells. Bars represent the 
average of four independent repeats ± SD. 
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The results of pyocyanin quantification of biofilm-cells were considered significant (p 
<0.05). Interestingly, for biofilm-cells, PAI2 strain produced a larger amount of 
pyocyanin (Figure 3.9). The remaining strains tested produced resembling amounts of 
pyocyanin (Figure 3.9) and these amounts were considered not significant (p >0.05). 
From these results, it is tempting to infer that P. aeruginosa way of growth influences 
the production of this pigment. As showed, the change to biofilm way of growth can 
augment or diminish the amount of pyocyanin produced. This evidence is noted for 
PA14 and PAI2 strains. The first produces a larger amount of pyocyanin when growing 
in planktonic form and this amount diminishes to irrelevant quantities when the growth 
is alternated to biofilm. As for the last strain, it is observed that the biofilm mode of 
growth can augment the pyocyanin production. 
In a clinical context this evidence may be considered important. Since P. aeruginosa is 
known for its ample biofilm forming ability in infected hosts, is essential to evaluate 
pyocyanin production of P. aeruginosa strains biofilm-cells. In cystic fibrosis patients 
pyocyanin has a severe toxic effect as it induces neutrophil apoptosis and damages the 
neutrophil-mediated host defense[19]. In recent developments, several substances, as 
peptides and proteins, have been used as quorum sensing and virulence factor 
inhibitors[19, 66, 67]. These substances caused the reduction and inhibition of pyocyanin 
production and therefore are a possible solution for the treatment of P. aeruginosa 
infections involving pyocyanin producing strains.  
 
3.2.4 Phenotypic switching 
 
Phenotypic switching or variation is considered a reversible state between two or more 
phenotypes. It is a common mechanism used by bacteria to increase their diversity and 
overcome environmental changes and exposure to stress conditions, as such phenotypic 
switching can be described as an adaptive mechanism. 
The most visible characteristic of phenotypic switching is colony morphology variation. 
Even though the connection between phenotypic switching and virulence and 
antimicrobial resistance is not completely understood the study of colony morphology 
can be a useful tool to understand which bacterial features were possibly changed and 
its association with external stimuli. 
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In this work, colony morphologies both from planktonic and biofilm-derived cells were 
recorded in order to establish whether bacteria mode of growth can affect colony 
morphology. For that, the number of colony morphotypes was registered and the results 
are shown in Figure 3.10 and Figure 3.11. It was also recorded the number of small-
colony morphotypes, a colony phenotype commonly associated with bacterial 
resistance. The colony classification system used is described in Appendix A (Tables 
A.1 and A.2). 
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Figure 3.10 Number of colony morphotypes registered for P. aeruginosa planktonic cells. Non-sCV 
stands for non-small-colony variant strain and sCV stands for small-colony variant. 
 
As showed in Figure 3.10 phenotypic variation was not registered for any P. aeruginosa 
planktonic-derived cells since every P. aeruginosa strain only exhibit one colony 
morphotype. The colony morphotypes recorded for planktonic cells are displayed in 
Appendix B (Figure B.1). 
In contrast, for biofilm-derived cells (Figure 3.11), the phenotypic variation 
phenomenon was observed since these cells were able to form two or more distinct 
colony morphotypes, being this observed for every P. aeruginosa strain. The colony 
morphotypes documented for biofilm-derived cells are presented in Appendix C (Figure 
C.1). 
 
  
37 
 
Phenotypic profiling of several strains of Pseudomonas aeruginosa: identification of potential virulence factors 
PA
O1
CE
CT
 
11
1
AT
CC
 
10
14
5
PA
14
PA
I1
PA
I2
PA
I3
0
2
4
6
8
10
sCVNon-sCV
N
u
m
be
r 
o
f M
o
rp
ho
ty
pe
s
 
Figure 3.11 Number of different colony morphotypes recorded for P. aeruginosa biofilm-derived cells. 
Non-sCV stands for non-small-colony variant strain and sCV stands for small-colony variant. 
 
When growing in biofilm-form, bacteria express a biofilm-specific phenotype, different 
from that assumed in the corresponding planktonic cells[49]. Changing the bacteria way 
of growth from planktonic to biofilm comprises a large number of phenotypic, 
physiological and metabolic differentiations[49]. These biofilm-associated phenotypic 
differentiations are often correlated with antimicrobial resistance, persistence and 
increased virulence. 
Moreover, when growing in biofilm-form bacteria can display a phenotypic 
heterogeneity as a result of a variety of microniches with specific biological activities 
within biofilms[49]. Therefore, biofilm diversity can be translated in distinct colonies due 
to those sub-populations[49]. This colony heterogeneity was observed for biofilm-derived 
cells in every P. aeruginosa strain studied as opposed to planktonic cells of the same 
strains which exhibit only one type of colony morphology. 
According to Stewart and Franklin[68], in a mature biofilm, three different physiological 
states can be expected: cells near the biofilm-bulk-fluid interface surrounded by an 
environment that contains both substrate and oxygen; cells in the intermediate zone 
surrounded by an environment that comprises only substrate; and cells in the deeper 
zone surrounded by an environment that does not contain oxygen or substrate. Cells 
near the biofilm-bulk-fluid interface can display similarities with the planktonic cells. 
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As so, some colonies formed by planktonic and biofilm-derived cells presented 
phenotypic similarities (Appendix B and C). These results lead to the conclusion that 
most of the cells recovered from P. aeruginosa biofilms were located in the more 
superficial layer of the biofilms. And because other colony phenotypes were observed it 
can be inferred that possibly biofilm-cells were also recovered from the remaining 
layers. 
The observed biofilm-associated phenotypic heterogeneity found in all strains studied 
only come to reinforce the fact that P. aeruginosa biofilms exhibit a great adaptability 
since biofilm-derived cells were able to form more than one colony morphotype. Yet the 
mechanisms that make this phenotypic variation occur are not entirely understood. It is 
also important to refer that all P. aeruginosa strains gave rise to a different number of 
biofilm-associated morphotypes, being PAI1 the P. aeruginosa strain that displayed the 
higher number of distinct biofilm-associated morphotypes (Figure 3.11). These 
differences can be attributed to the different genetic background of all P. aeruginosa 
strains used. 
Moreover phenotypic variation is also considered as a way to escape host immune 
mechanisms since it is related with several human pathogens. Since phenotypic 
switching affects host-pathogen interactions, it confers human pathogens the ability to 
evade innate and acquired immune defenses during colonization and infection[69]. 
Subpopulations created by phenotypic variation have the ability to exhibit different 
kinds of antigens and the host’s immune system only reacts to those recognized. Thus, 
the immune system is incapable to successfully eliminate those pathogens[49]. This 
evading mechanism resides in the antigenic variation principle. Although if bacteria are 
able to switch off the expression of a determined antigen, the biological function 
associated with that antigen can be lost. So in order to maintain the biological function 
related with that antigen functional redundancy is essential. However, the frequency by 
which antigen variation arises is yet to be fully understood and studied[69].   
Taking into account this concept of enhanced virulence it is correct to hypothesize that 
all P. aeruginosa strains studied when growing in biofilm-form display some type of 
evade mechanisms to the host’s immune system once all strains exhibited more than one 
kind of colony morphotype (Figure 3.11). Once more, PAI1 strain can be highlighted 
since it was the P. aeruginosa strain that displayed a larger number of colony 
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morphotypes and, therefore, can be noted as the P. aeruginosa strain among those 
studied with the higher ability to elude the host’s immune system. 
Phenotypic variation can also lead to the development of microcolonies, denominated 
small-colony variants (sCV). The development of such colony morphotype is exhibited 
by several bacterial species, including P. aeruginosa. To be considered a sCV 
morphotype, P. aeruginosa colonies must have a diameter equal or smaller than 3 mm. 
Some of the P. aeruginosa strains studied displayed sCV (Figure 3.12) when growing in 
biofilm-form (Figure 3.11) but planktonic cells did not develop these microcolonies 
(Figure 3.10). 
Besides enabling bacteria to escape the host’s immune system, phenotypic switching 
also influences bacteria antimicrobial resistance. Currently standard therapeutic 
treatments and disinfection procedures are becoming less effective in eradicating human 
pathogens and, on the other hand, the antimicrobial over-using is augmenting the 
emergence of resistant bacteria[49]. Bacterial resistance comprises several types of 
mechanisms such as low outer-membrane permeability and efflux pumps, for example. 
However, in an earlier study Massey et al.[70] reported that Staphylococcus aureus 
exposure to gentamicin resulted in the emergence of sCV and in the absence of 
gentamicin these sCV were able to revert to normal phenotype.  
Figure 3.12 Small-colony variants (sCV) registered for P. aeruginosa biofilm-derived cells. 
PAO1 ATCC 10145 PA14 
PAI1 
PAI3 
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In the light of these findings, it can be said that sCV morphotypes may be associated 
with antimicrobial resistance, causing bacterial persistence and pathogenicity.  
Therefore, the sCV morphotype is indeed associated with a better adaptive ability of 
bacteria to environmental changes and stress. Although planktonic cells did not exhibit 
sCV morphotype, this morphotype is not as exclusively a biofilm-specific phenotype, as 
demonstrated before[71]. Therefore, it is unclear the existence of a particular morphotype 
that could characterize exclusively a biofilm-associated phenotype. 
In this work, when growing in biofilm-form, some P. aeruginosa strains, among those 
PAO1, ATCC 10145, PA14, PAI1, and PAI3, developed sCV morphotypes (Figure 
3.12) and PAI1 strain was the one that developed a larger number of those morphotypes. 
Given these evidences, it was expected that these strains presented a higher resistance to 
the antibiotics used in this study. However this fact was not observed once all strains 
exhibit similar resistance both to ciprofloxacin and colistin. To further comprise the 
relation of antimicrobial resistance and sCV morphotypes it is necessary to isolate these 
colonies and expose them to antibiotic stress. 
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CHAPTER 4. CONCLUSION 
In this final Chapter the main conclusions of this work are presented. Some future 
perspectives are also addressed. 
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Nowadays, in clinical settings the increased resistance of bacteria, including P. 
aeruginosa, leads to an augmented infection persistence and causes an increase of the 
morbidity and mortality associated with those infections. 
In natural scenarios, bacteria grow in organized communities called biofilms. Within the 
biofilm community, bacteria assume distinct phenotypes which contribute to biofilm 
adaptation to different environments, stress conditions and resistance to several 
antimicrobials. Therefore it is important to understand if biofilms formed by different P. 
aeruginosa strains share some characteristics. However it was not verified a common P. 
aeruginosa biofilm profile. And there was not verified a direct relationship between all 
virulence factors studied. Due to this variability in the biofilm characteristics studied no 
strain was considered more virulent than other strain. For instance, since they already 
have been exposed to several stress conditions, it was expected that clinical isolates 
showed a greater virulence. However, because of the variability found that was not 
verified.  
As shown in Chapter 3, the seven strains of P. aeruginosa studied have different 
biofilm-forming ability. The biofilm-forming ability can be related with increased 
virulence and resistance. However, in this study, a greater biofilm-forming aptitude did 
not translate in a higher resistance against the antibiotics used since the resistance 
profile against ciprofloxacin and the susceptibility profile against colistin were found to 
be very similar among all P. aeruginosa strains tested. 
Biofilm-associated resistance in P. aeruginosa is still poorly understood and involves 
several complex mechanisms[72] and those mechanisms can be basically caused by: (i) 
the low outer-membrane permeability, which difficult the antimicrobial agents 
penetration within the biofilm; (ii) the limited gradients of oxygen and nutrients in the 
deeper layers of the biofilm, causing cells to grow slower; and (iii) the emergence of 
phenotypic and persister phenotypes. As referred above, in Chapter 3, all P. aeruginosa 
strains studied revealed similar resistance profile against ciprofloxacin and equal 
susceptibility profile against colistin,  with the exception of PAI3 (Table 3.1) which 
revealed a higher resistance to ciprofloxacin. The same results showed that the use of 
ciprofloxacin in the treatment of P. aeruginosa-related infections is an ineffective and 
outdated therapeutic method since all P. aeruginosa strains were resistant to this 
antibiotic. Therefore, actual clinical guidelines should be reconsidered and the use of 
ciprofloxacin as an empirical therapy for P. aeruginosa infections should be replaced. 
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Moreover, the usage and misusage of antibiotics, such as ciprofloxacin, have been 
associated with increased resistance and infection persistence. For instance, colistin 
would be a great replacement of ciprofloxacin since all strains studied displayed to be 
susceptible to this antibiotic. However, due to its severe toxicity, colistin is considered a 
last resort antibiotic. In recent years, studies show that antibiotic combinatory therapies 
are indeed effective in killing P. aeruginosa isolates even under biofilm conditions and 
some of these combinatory therapies combine ciprofloxacin and colistin with other 
antibiotics and even with each other[73]. Moreover, due to the increased resistance 
caused by the use of antibiotics, recently agents that antagonize virulence factors have 
been developed, representing a potentially efficient approach to the treatment of 
infections caused by P. aeruginosa[4]. 
Besides biofilm-associated resistance, P. aeruginosa displays several virulence factors 
imperative to its pathogenesis. For instance, all P. aeruginosa strains studied have 
specific motility abilities. These particular motility abilities influence the biofilm way of 
life, in the sense that they are often related with increased virulence and possibly higher 
resistance. However, given this study results, there was not a clear link between the 
motility abilities studied, biofilm-forming ability, and increased resistance. To further 
understand these relations future works should be done in order to characterize 
proteomic and genetically the mechanisms comprised in the presence and loss of the 
organelles responsible for bacterial motility throughout the different stages of biofilm 
formation and under antibiotic stress. 
Slime production ability is also a virulence factor that is often implied in increased 
biofilm-resistance and biofilm formation. Based on the results found in this work, there 
is not a connection between slime production, increased resistance and biofilm 
formation. 
The ability of P. aeruginosa to produce extracellular toxins is also a very important 
virulence factor. These toxins often lead to serious consequences in patients and even to 
death. In this work hemolysin and pyocyanin production were evaluated. All P. 
aeruginosa strains revealed distinct production and release of the extracellular toxins 
studied. From the pathogenic point of view, hemolysin and pyocyanin production seem 
to be quite important, since they contribute to bacterial ability to avoid the host’s 
immune system. Hemolytic activity of P. aeruginosa is translated in increased vascular 
permeability, organ damage, and even host’s death, as for pyocyanin it has a relevant 
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role in pathogenesis of cystic fibrosis, causing neutrophil apoptosis and damaging the 
neutrophil-mediated host defense. Although the expression of these virulence factors 
was evaluated, it was concluded that all P. aeruginosa strain had different virulence 
profiles, meaning that was not any strain considered more virulent than other. Similarly 
to motility abilities of P. aeruginosa, future works could focus the proteomic profiling 
and genetic characterization of the apparatuses that lead to the production of these 
extracellular toxins in order to identify possible drug targets and the development of 
agents that are able to inhibit or reduce the severe effects caused by these toxins. 
Lastly, biofilm development embodies a key strategy to bacterial survival. Phenotypic 
switching offers a source of bacterial diversity central to the survival in diverse and 
hostile environments since it presents several variants that are able to persist to different 
types of stress conditions. Also, phenotypic variation has been connected with increase 
virulence and bacterial resistance. For instance, the best evidence of this connection is 
the alteration of resistance and virulence profiles showed by sCV. However, the link 
between biofilms and biofilm-specific colony morphotypes is yet to be understood. 
Therefore, it is essential to comprehend how phenotypic switching contributes to 
antimicrobial resistance and infection persistence. Also, it is imperative to identify 
biofilm-associated colony morphologies and understand their role in biofilm mode of 
growth, chronic infections and increased bacterial resistance. In short, the understanding 
of the phenotypic switching phenomena is necessary to develop suitable disinfection 
and therapeutic protocols. The awareness of the phenotypic variation has a significant 
importance in clinical settings, since it can solve real issues, such as antimicrobial 
resistance and development of new therapeutic methodologies. 
In summary, it is important to note that there is not an universal P. aeruginosa biofilm 
profile. Although resistance and susceptibility profiles against ciprofloxacin and 
colistin, respectively, were found to be identical for all strains tested, all virulence 
factors tested were found variable. And, based on the results obtained, it was not 
established an evident connection among those. Furthermore, as all P. aeruginosa 
strains showed resistance against ciprofloxacin, there is an urgent need to reconsider the 
use of this antibiotic as an empirical treatment against P. aeruginosa related infections. 
As such, actual clinical guidelines should be improved. These guidelines should regard 
phenotypic switching, intrinsic responses of biofilms to antibiotic and environmental 
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stress and virulence factors presented by P. aeruginosa biofilms, characteristics with the 
most potential therapeutic impact. 
The information collected with this thesis contributes to a better understanding of P. 
aeruginosa biofilms characteristics. These findings can be the basis to new 
investigations that can lead to a further understanding of P. aeruginosa adaptive 
resistance and even to the improvement of strategies of biofilm control, eradication of 
already established biofilms, and prevention and control of P. aeruginosa related 
infections.  
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APPENDIX 
 
APPENDIX A – COLONY CLASSIFICATION SYSTEM 
Table A.1 Morphological criteria of colony classification system 
Class Sub-class 
Form Circular 
Elliptical 
Erose 
Filamentous 
Irregular 
Rhizoid  
  
Margin Entire 
Filamentous 
Irregular 
Lobate 
Undulate 
  
Surface Heterogeneous 
Homogeneous 
  
Texture Concentric 
Rugose 
Smooth 
Striated 
Wrinkled 
  
Sheath Absent 
Present 
  
Opacity Iridescent 
Opaque 
Translucent 
Transparent 
  
Elevation Convex 
Crateriform 
Flat 
Pulvinate 
Raised 
Umbonate 
  
Size Large 
Small 
  
Colour White 
Yellow 
Yellowish 
Green 
  
Diameter  
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Table A.2 Morphological Concepts 
Term Concept Synonymous 
Elliptical Form feature inhering in a colony virtue to present an 
oval configuration with two axes of symmetry, as 
produced by a conical section. 
Elliptic, ellipsoid, 
ellipse-shaped, oval, 
ovoid 
   
Erose Form feature inhering in a colony by virtue of having 
an irregularly toothed shape 
Jagged, toothed, 
notched, serrated, 
dentated 
   
Filamentous Form features inhering in a colony by virtue of having 
filamentous extensions at its edge 
 
   
Irregular Morphological feature inhering in a colony by virtue of 
not having any distinguishable configuration 
 
   
Rhizoid Form feature inhering in a colony by virtue of having 
extensions radiating from its center 
Rhizoidal 
   
Entire Margin feature inhering in a colony by virtue of having 
a straight well-defined line border without irregularities 
or other projections 
 
   
Lobate Margin feature inhering in a colony by virtue of having 
deeply undulating edges forming lobes 
Lobular 
   
Undulate Margin feature inhering in a colony by virtue of having 
a sinuate and rippled margin 
Rippled, sinuate, 
undulated, wavy, 
undulating, waved  
   
Heterogeneous Surface feature inhering in a colony by virtue of having 
more than one type of texture 
 
   
Homogeneous Surface feature inhering in a colony by virtue of having 
only one type of texture 
Uniform 
   
Concentric Texture feature inhering in a colony by virtue of having 
vertical irregularities in a configuration of a 
circumference or a circle 
Concentrical 
   
Rugose Texture feature inhering in a colony by virtue of having 
small vertical irregularities 
Rough, rugous 
   
Smooth Texture feature inhering in a colony by virtue of having 
a surface free of roughness or vertical irregularities 
 
   
Striated Texture feature inhering in a colony by virtue of having 
vertical irregularities marked by narrow lines or 
grooves, usually parallel 
 
   
Wrinkled Texture feature inhering in a colony by virtue of having 
large vertical irregularities 
 
   
(Sheath) Absence Morphological quality inhering in a colony by virtue of 
not having a sheath around the colony 
 
   
(Sheath) Presence Morphological quality inhering in a colony by virtue of 
having a sheath around the colony 
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Iridescent Optical quality inhering in a colony by virtue of 
changing colour as the angle of view changes 
 
   
Opaque Optical quality inhering in a colony by virtue of not 
transmitting or reflecting light or radiant energy 
 
   
Translucent Optical quality inhering in a colony by virtue of 
exhibiting low opacity 
 
   
Transparent Optical quality inhering in a colony by virtue of 
lacking opacity 
 
   
Convex Elevation feature inhering in a colony by virtue of the 
surface curves or bulges outward, like the exterior of a 
circle or sphere 
 
   
Crateriform Elevation feature inhering in a colony by virtue of the 
surface becoming plane with a crater or a hold or a 
cavity 
 
   
Flat Elevation feature inhering in a colony by virtue of the 
surface becoming more extended in a plane 
Flattened, 
compressed 
   
Pulvinate Elevation feature inhering in a colony by virtue of the 
surface being shaped like a cushion or has a marked 
convex cushion-like form 
 
   
Raised Elevation feature inhering in a colony by virtue of the 
surface becoming rounded out 
Rounded out, 
embossed, lifted 
   
Umbonate Elevation feature inhering in a colony by virtue of the 
surface having a rounded knob or knoblike 
protuberance 
 
 
  
  
56 
 
Phenotypic profiling of several strains of Pseudomonas aeruginosa: identification of potential virulence factors 
APPENDIX B – PLANKTONIC COLONY MORPHOTYPES 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
PAI3 
PAI2 PAI1 PA14 
ATCC 10145 CECT 111PAO1 
Figure B.1 Colony morphotypes registered for P. aeruginosa planktonic cells. 
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APPENDIX C – BIOFILM-DERIVED COLONY MORPHOTYPES 
PAI3 
PAI2 
PAI1 
PA14 
ATCC 10145 
CECT 111
PAO1 
Figure C.1 Colony morphotypes registered for P. aeruginosa biofilm-derived cells. 
